This article reviews the history of the Journal of Studies on Alcohol and Drugs as well as the Rutgers Center of Alcohol Studies. Each has its roots in the Yale Laboratory of Applied Physiology and the era shortly after the repeal of National Prohibition in the United States. The journal was founded as the Quarterly Journal of Studies on Alcohol in 1940 by Howard W. Haggard, M.D., director of the Yale Laboratory of Physiology. Alcohol, although not originally the sole focus of the laboratory, eventually became the main and then only focus. A Section of Alcohol Studies and later Center of Alcohol Studies formally became components of the laboratory. The faculty grew to include notable figures such as Elvin Morton Jellinek and Mark Keller, among other influential people who helped establish a modern, multidisciplinary, scientific approach to alcohol problems in the United States. The first alcohol education program, originally called the Summer Session of the School of Alcohol Studies, was also founded there in 1943. The center later moved to Rutgers University in New Jersey, becoming the Rutgers Center of Alcohol Studies in 1962. With it came the summer school and the Quarterly Journal of Studies on Alcohol, which in 1975 became the Journal of Studies on Alcohol. The journal again changed names in 2007, becoming the Journal of Studies on Alcohol and Drugs, reflecting an increasing focus among substance use researchers on drugs other than alcohol. This article discusses the influence of the journal and the center in the larger historical context of alcohol studies throughout the 20th century to the modern day.
Download full-text PDF |
Source |
---|
JAMA Netw Open
January 2025
School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
JAMA Netw Open
January 2025
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts.
Importance: During buprenorphine treatment for opioid use disorder (OUD), risk factors for opioid relapse or treatment dropout include comorbid substance use disorder, anxiety, or residual opioid craving. There is a need for a well-powered trial to evaluate virtually delivered groups, including both mindfulness and evidence-based approaches, to address these comorbidities during buprenorphine treatment.
Objective: To compare the effects of the Mindful Recovery Opioid Use Disorder Care Continuum (M-ROCC) vs active control among adults receiving buprenorphine for OUD.
Ann Surg Oncol
January 2025
Department of Medical Oncology, Clinical Oncology School of Fujian Medical University, Fujian Cancer Hospital, Fuzhou, Fujian, China.
Background: Colon and rectum cancer (CRC) is a major health burden in China, with notable gender disparities. This study was designed to analyze trends in CRC incidence, prevalence, and mortality from 1990 to 2021 and to project future trends.
Methods: Using data from the Global Burden of Disease (GBD) Study 2021, we examined CRC burden in China, including incidence, prevalence, mortality, disability-adjusted life years (DALYs), years lived with disability (YLDs), and years of life lost (YLLs).
Appl Microbiol Biotechnol
January 2025
Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern, Freiestrasse 3, 3012, Bern, Switzerland.
A new strategy has been developed to successfully produce the active component danshensu ex vivo. For this purpose, phenylalanine dehydrogenase from Bacillus sphaericus was combined with the novel hydroxyphenylpyruvate reductase from Mentha x piperita, thereby providing an in situ cofactor regeneration throughout the conversion process. The purified enzymes were co-immobilized and subsequently employed in batch biotransformation, resulting in 60% conversion of 10 mM L-dopa within 24 h, with a catalytic amount of NAD as cofactor.
View Article and Find Full Text PDFPsychol Trauma
January 2025
VA New England Mental Illness Research, Education and Clinical Center, VA Connecticut Health Care System.
Objective: To elucidate the relationship between impaired sleep duration and trauma/posttraumatic stress disorder (PTSD) net of sociodemographic, behavioral, and comorbid diagnostic factors.
Method: We investigated this relationship using the National Epidemiologic Survey on Alcohol and Related Conditions-III data set, analyzing a nationally representative sample of 36,309 adults. Our study identified three groups: those without trauma/PTSD, those with trauma but no PTSD, and those with PTSD.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!